Metastatic Rectal Carcinoma with Long-Term Remission due to Modern Multimodality Treatment

In the era of personalized medicine, systemic treatment with chemotherapy in combination with targeted drugs, tailored according to RAS and BRAF status, has improved the survival of patients with metastatic colorectal cancer (mCRC), but curative resection of metastases provides the only chance of cu...

Descripción completa

Detalles Bibliográficos
Autores principales: Eigeliene, Natalja, Saarenheimo, Jatta, Wichmann, Viktor, Österlund, Pia, Jekunen, Antti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613627/
https://www.ncbi.nlm.nih.gov/pubmed/34899239
http://dx.doi.org/10.1159/000519044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613627/
https://www.ncbi.nlm.nih.gov/pubmed/34899239
http://dx.doi.org/10.1159/000519044

Ejemplares similares